IMAX Corporation (IMAX) — closed signal from July 9, 2025
Target reached Published before the outcome was known, scored automatically when the window closed on October 7, 2025 — +21.8% at the close.
Predicted vs. what happened
What happened
Reached its target in 61 days.
The thesis — published July 9, 2025
IMAX turns 40% of its sales into extra cash, but the share price has slid 15% and is valued like a regular theater chain. Short-term trading signals hint buyers may return. Benchmark kept its $30 target on Jul 9 after IMAX screens captured a record share, helped by "F1 The Movie" bringing in $28 million. With more summer hits coming, the stock could climb back above $30.
Primary drivers
- Short-term signal shows the stock may have fallen too far and could bounce soon.
- On July 9, research firm Benchmark repeated its $30 price goal.
- The company turns a big chunk of sales into cash because it owns few hard assets.
- Summer hit movies are sending more viewers to IMAX screens than ever.
How it played out
IMAX: target reached in 61 days
Lyra published IMAX on July 9, 2025 at $26.90. The thesis expected 16% growth and pointed to a short-term bounce setup after a 15% slide, Benchmark's $30 price goal on July 9, cash generation from a light asset base, and summer films sending more viewers to IMAX screens.
Inside the window, the stock reached the $31.20 goal in 61 days. It later peaked at $34.14 on October 3, with a 26.9% peak gain. It ended the window at $32.77. The thesis played out.
What happened during the window
On September 18, 2025, Axios reported that Netflix's "Frankenstein" would have a limited IMAX theatrical run. The article tied the item to comments from IMAX CEO Richard Gelfond at Axios Media Trends Live.
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.